121 related articles for article (PubMed ID: 6432761)
1. The myxovalargins, new peptide antibiotics from Myxococcus fulvus (Myxobacterales). I. Cultivation, isolation, and some chemical and biological properties.
Irschik H; Gerth K; Kemmer T; Steinmetz H; Reichenbach H
J Antibiot (Tokyo); 1983 Jan; 36(1):6-12. PubMed ID: 6432761
[TBL] [Abstract][Full Text] [Related]
2. The myxovirescins, a family of antibiotics from Myxococcus virescens (Myxobacterales).
Gerth K; Irschik H; Reichenbach H; Trowitzsch W
J Antibiot (Tokyo); 1982 Nov; 35(11):1454-9. PubMed ID: 6819280
[TBL] [Abstract][Full Text] [Related]
3. The myxopyronins, new inhibitors of bacterial RNA synthesis from Myxococcus fulvus (Myxobacterales).
Irschik H; Gerth K; Höfle G; Kohl W; Reichenbach H
J Antibiot (Tokyo); 1983 Dec; 36(12):1651-8. PubMed ID: 6420386
[TBL] [Abstract][Full Text] [Related]
4. The myxalamids, new antibiotics from Myxococcus xanthus (Myxobacterales). I. Production, physico-chemical and biological properties, and mechanism of action.
Gerth K; Jansen R; Reifenstahl G; Höfle G; Irschik H; Kunze B; Reichenbach H; Thierbach G
J Antibiot (Tokyo); 1983 Sep; 36(9):1150-6. PubMed ID: 6415031
[TBL] [Abstract][Full Text] [Related]
5. Myxothiazol, an antibiotic from Myxococcus fulvus (myxobacterales). I. Cultivation, isolation, physico-chemical and biological properties.
Gerth K; Irschik H; Reichenbach H; Trowitzsch W
J Antibiot (Tokyo); 1980 Dec; 33(12):1474-9. PubMed ID: 6788741
[TBL] [Abstract][Full Text] [Related]
6. A macrocyclic antibiotic M-230B produced by Myxococcus xanthus. Isolation and characterization.
Onishi N; Izaki K; Takahashi H
J Antibiot (Tokyo); 1984 Jan; 37(1):13-9. PubMed ID: 6421789
[TBL] [Abstract][Full Text] [Related]
7. Production, isolation, physico-chemical and biological properties of angiolam A, a new antibiotic from Angiococcus disciformis (Myxobacterales).
Kunze B; Kohl W; Höfle G; Reichenbach H
J Antibiot (Tokyo); 1985 Dec; 38(12):1649-54. PubMed ID: 3937837
[TBL] [Abstract][Full Text] [Related]
8. The mechanism of action of myxovalargin A, a peptide antibiotic from Myxococcus fulvus.
Irschik H; Reichenbach H
J Antibiot (Tokyo); 1985 Sep; 38(9):1237-45. PubMed ID: 2415501
[TBL] [Abstract][Full Text] [Related]
9. Saframycin Mx1, a new natural saframycin isolated from a myxobacterium.
Irschik H; Trowitzsch-Kienast W; Gerth K; Höfle G; Reichenbach H
J Antibiot (Tokyo); 1988 Aug; 41(8):993-8. PubMed ID: 2459096
[TBL] [Abstract][Full Text] [Related]
10. The aurachins, new quinoline antibiotics from myxobacteria: production, physico-chemical and biological properties.
Kunze B; Höfle G; Reichenbach H
J Antibiot (Tokyo); 1987 Mar; 40(3):258-65. PubMed ID: 3106289
[TBL] [Abstract][Full Text] [Related]
11. The primary structure of fulvocin C from Myxococcus fulvus.
Tsai H; Hirsch HJ
Biochim Biophys Acta; 1981 Jan; 667(1):213-7. PubMed ID: 6783114
[TBL] [Abstract][Full Text] [Related]
12. A novel antibiotic, sohbumycin. Taxonomy, fermentation, isolation and physico-chemical and biological characteristics.
Umezawa I; Tronquet C; Funayama S; Okada K; Komiyama K
J Antibiot (Tokyo); 1985 Aug; 38(8):967-71. PubMed ID: 3840156
[TBL] [Abstract][Full Text] [Related]
13. The corallopyronins, new inhibitors of bacterial RNA synthesis from Myxobacteria.
Irschik H; Jansen R; Höfle G; Gerth K; Reichenbach H
J Antibiot (Tokyo); 1985 Feb; 38(2):145-52. PubMed ID: 2581926
[TBL] [Abstract][Full Text] [Related]
14. FRUITING BODY POPULATIONS OF MYXOCOCCUS FULVUS (MYXOBACTERALES).
FLUEGEL W
Growth; 1965 Jun; 29():183-91. PubMed ID: 14324921
[No Abstract] [Full Text] [Related]
15. Bacteriocins from Myxococcus fulvus (Myxobacterales).
Hirsch HJ
Arch Microbiol; 1977 Oct; 115(1):45-9. PubMed ID: 412477
[TBL] [Abstract][Full Text] [Related]
16. Stigmatellin, a new antibiotic from Stigmatella aurantiaca (Myxobacterales). I. Production, physico-chemical and biological properties.
Kunze B; Kemmer T; Höfle G; Reichenbach H
J Antibiot (Tokyo); 1984 May; 37(5):454-61. PubMed ID: 6429114
[TBL] [Abstract][Full Text] [Related]
17. The sorangicins, novel and powerful inhibitors of eubacterial RNA polymerase isolated from myxobacteria.
Irschik H; Jansen R; Gerth K; Höfle G; Reichenbach H
J Antibiot (Tokyo); 1987 Jan; 40(1):7-13. PubMed ID: 3104268
[TBL] [Abstract][Full Text] [Related]
18. Purification and partial characterization of an antibiotic produced by Myxococcus xanthus.
Vaks B; Zuckerberg A; Rosenberg E
Can J Microbiol; 1974 Feb; 20(2):155-61. PubMed ID: 4362757
[No Abstract] [Full Text] [Related]
19. New polyenic antibiotics active against gram-positive and -negative bacteria. I. Isolation and purification of antibiotics produced by Gluconobacter sp. W-315.
Watanabe T; Izaki K; Takahashi H
J Antibiot (Tokyo); 1982 Sep; 35(9):1141-7. PubMed ID: 6216233
[TBL] [Abstract][Full Text] [Related]
20. Isolation and identification of althiomycin from Cystobacter fuscus (myxobacterales).
Kunze B; Reichenbach H; Augustiniak H; Höfle G
J Antibiot (Tokyo); 1982 May; 35(5):635-6. PubMed ID: 6809724
[No Abstract] [Full Text] [Related]
[Next] [New Search]
